EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The genotypic and phenotypic landscape of PDHA1 -related pyruvate dehydrogenase complex deficiency

Kajus Merkevicius iD, Dmitrii Smirnov, Lea D Schlieben, Rebecca Ganetzky iD, René G Feichtinger, Huafang Jiang, Fang Fang, Tomohiro Ebihara, Kei Murayama iD, Giulia Ferrera, Anna Ardissone iD, Dariusz Rokicki und 48 weitere

Brain · 2026

DOI: 10.1093/brain/awaf430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2026. Verfasst von Kajus Merkevicius und 59 weiteren Autor:innen. Beteiligte Einrichtung: Expertise Centre for Mitochondrial Diseases (Mitohaus), University Children's Hospital, Paracelsus Medical University (PMU) Salzburg, Salzburg 5020, …. Hauptthemen laut MEDLINE: Pyruvate Dehydrogenase Complex Deficiency Disease, Pyruvate Dehydrogenase (Lipoamide). Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, National Institute for Health Research, Department of Health and Social Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective study on X-linked PDHA1-related pyruvate dehydrogenase complex (PDHc) deficiency combined a systematic literature review with a multicentre survey exploring genotypes, phenotypes and survival. Data from 891 individuals (45% unpublished) were included. Of note, 53% of cases were females. Median age at last assessment was 6 years (range 0–80 years, n = 622). We detected 331 different (118 unpublished) PDHA1 variants, of which 75% (305/405) had occurred de novo. Variants in this study were uploaded to ClinVar (SCV006297015—SCV006297345). The 10 most frequent variants accounted for 36% of the diagnoses. Sixty-nine per cent of the variants were private; missense (50%) and frameshift (20%) variants were most common. Frameshift/nonsense (FS/N) variants in males (44/401, 11%) were confined to regions escaping nonsense-mediated decay (NMD) and were significantly less frequent than in females (151/461, 33%). Neonatal or infantile (405/529, 77%) presentations were most frequent, with pre/perinatal abnormalities reported in 47% (159/342). FS/N variants in the NMD-predicted region 3.9 [95% confidence interval (CI) 1.54–11.04] times increased the odds of fetal findings. Females presented significantly earlier [2 months, interquartile range (IQR) 7.0, n = 224] than males (8 months, IQR 16.6, n = 233), with increased risk of neonatal presentation [odds ratio (OR) 3.01 (95% CI 1.279–7.616)] when harbouring FS/N variants in the NMD-predicted region. The overall (n = 242) mean survival time was 10.9 (95% CI 9.9–11.9) years. On average, females survived 4.5 (95% CI 2.62–6.40) years longer than males despite presenting more severe phenotypes. Poor survival was associated with male sex [hazard ratio (HR) 3.3 (95% CI 1.95–5.62)], neonatal presentation [HR 5.5 (95% CI 2.17–14.09)], FS/N variants in the NMD-predicted region [HR 4.0 (95% CI 1.78, 9.16)] and splice variants [HR 2.3 (95% CI 1.15, 4.59)]. More severe clinical phenotypes were predicted by neonatal or infantile presentations and by female sex. Developmental delay (DD), intellectual disability (ID), muscle hypotonia, abnormal movements, seizures, feeding difficulties and microcephaly were the most frequent phenotypes, all occurring in more than half. Corpus callosum or basal ganglia alterations and cerebral atrophy were common. Four per cent (36/891) were reported to have mild phenotypes with no DD nor ID (25/36 males). This is the largest dataset on a nuclear-encoded defect of mitochondrial energy metabolism. The genotypic and phenotypic details further defines the disease landscape and can be used for variant interpretation. The correlations between genotypes, sex, phenotypes and survival, adds substantial improvement to counselling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyruvate Dehydrogenase Complex Deficiency DiseasePyruvate Dehydrogenase (Lipoamide)HumansFemaleMalePhenotypeGenotypeInfantChild, PreschoolAdolescentChildMiddle AgedAdultAgedAged, 80 and overInfant, NewbornYoung AdultRetrospective Studies

Stichwörter der Autor:innen

genotype-phenotype correlationinborn errors of metabolisminborn metabolic diseaseketogenic dietmitochondrial diseasetreatment

Substanzen

Pyruvate Dehydrogenase (Lipoamide)pyruvate dehydrogenase E1alpha subunit

Autor:innen und Institutionen

  • Expertise Centre for Mitochondrial Diseases (Mitohaus), University Children's Hospital, Paracelsus Medical University (PMU) Salzburg, Salzburg 5020, Austria.
  • Faculty of Medicine, Clinic of Paediatrics, Institute of Clinical Medicine, Vilnius University, Vilnius 03101, Lithuania.
  • Institute of Biosciences, Life Sciences Center, Vilnius University, Vilnius 10257, Lithuania.
  • School of Medicine, Institute of Human Genetics, Klinikum Rechts der Isar, Technical University of Munich, Munich 81675, Germany.
  • Institute of Neurogenomics, Computational Health Centre, Helmholtz Zentrum München, Neuherberg 85764, Germany.
  • Department of Pediatrics, Division of Human Genetics, Mitochondrial Medicine Frontier Program, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

ORCID-Profile: Kajus Merkevicius, Rebecca Ganetzky, Kei Murayama, Anna Ardissone, Matias Wagner, Fowzan Alkuraya, Andrea Bevot, Felix Distelmaier, Marni J Falk, Thomas Klopstock

Förderung

  • Bundesministerium für Bildung und Forschung
  • National Institute for Health Research
  • Department of Health and Social Care
  • Estonian Research

Zitieren

APA

Merkevicius, K., Smirnov, D., Schlieben, L. D., Ganetzky, R., Feichtinger, R. G., Jiang, H., Fang, F., Ebihara, T., Murayama, K., Ferrera, G., Ardissone, A., Rokicki, D., Wesol-Kucharska, D., Schröder, S., Bauer, P., Bertoli-Avella, A., Østergaard, E., Freisinger, P., Janssen, M. C. H., …, & Klopstock, T. (2026). The genotypic and phenotypic landscape of PDHA1 -related pyruvate dehydrogenase complex deficiency. Brain. https://doi.org/10.1093/brain/awaf430

Vancouver

Merkevicius K, Smirnov D, Schlieben LD, Ganetzky R, Feichtinger RG, Jiang H, et al. The genotypic and phenotypic landscape of PDHA1 -related pyruvate dehydrogenase complex deficiency. Brain. 2026. doi:10.1093/brain/awaf430

BibTeX
@article{Merkevicius2026,
  author = {Merkevicius, Kajus and Smirnov, Dmitrii and Schlieben, Lea D and Ganetzky, Rebecca and Feichtinger, René G and Jiang, Huafang and Fang, Fang and Ebihara, Tomohiro and Murayama, Kei and Ferrera, Giulia and Ardissone, Anna and Rokicki, Dariusz and Wesol-Kucharska, Dorota and Schröder, Sabine and Bauer, Peter and Bertoli-Avella, Aida and Østergaard, Elsebeth and Freisinger, Peter and Janssen, Mirian C H and Wagner, Matias and Abouyousef, Omar and Alhaddad, Bader and AlAbdi, Lama and Alkuraya, Fowzan and Alston, Charlotte L and Baghdasaryan, Anna and Barca, Diana and Barić, Ivo and Bellusci, Marcello and Bevot, Andrea and Boltshauser, Eugen and Borggraefe, Ingo and Bouchereau, Juliette and Bruno, Claudio and Burnyte, Birute and Calhoun, Amy and Casas, Kari and Coker, Mahmut and Crushell, Ellen and De Lonlay, Pascal and Dionisi-Vici, Carlo and Distelmaier, Felix and Falk, Marni J and Ferreira, Ana Cristina and Ferreira, Carlos R and Ficicioglu, Can and Gokçay, Gulden Fatma and Häberle, Johannes and Heath, Oliver and Hellenschmidt, Albrecht and Hoefele, Julia and Hoffmann, Georg F and Honzik, Tomas and Huemer, Martina and Janeiro, Patrícia and Karaa, Amel and Kasapkara, Çiğdem Seher and Kern, Ilse and Klepper, Joerg and Klopstock, Thomas},
  title = {The genotypic and phenotypic landscape of PDHA1 -related pyruvate dehydrogenase complex deficiency},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awaf430}
}
Kostenlos starten →